Kewaunee Scientific (NASDAQ:KEQU) Issues Earnings Results

Kewaunee Scientific (NASDAQ:KEQU) issued its earnings results on Tuesday. The technology company reported $1.14 earnings per share for the quarter, Zacks reports. The firm had revenue of $71.40 million for the quarter. Kewaunee Scientific had a net margin of 3.41% and a return on equity of 14.39%. During the same quarter in the prior year, the business earned $1.95 EPS.

Kewaunee Scientific Stock Down 3.6%

NASDAQ:KEQU opened at $34.00 on Thursday. The firm’s 50 day simple moving average is $37.70 and its 200 day simple moving average is $38.03. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.12 and a quick ratio of 1.45. Kewaunee Scientific has a one year low of $33.27 and a one year high of $60.89. The company has a market cap of $97.58 million, a PE ratio of 10.56 and a beta of 0.70.

Hedge Funds Weigh In On Kewaunee Scientific

Several large investors have recently modified their holdings of KEQU. First Trust Advisors LP grew its stake in shares of Kewaunee Scientific by 3.4% in the second quarter. First Trust Advisors LP now owns 6,726 shares of the technology company’s stock worth $395,000 after purchasing an additional 222 shares during the last quarter. Geode Capital Management LLC raised its position in Kewaunee Scientific by 0.9% during the 2nd quarter. Geode Capital Management LLC now owns 24,013 shares of the technology company’s stock worth $1,410,000 after purchasing an additional 223 shares during the last quarter. State Street Corp raised its position in Kewaunee Scientific by 4.2% during the 4th quarter. State Street Corp now owns 10,034 shares of the technology company’s stock worth $375,000 after purchasing an additional 400 shares during the last quarter. US Bancorp DE lifted its holdings in Kewaunee Scientific by 80.0% during the 3rd quarter. US Bancorp DE now owns 900 shares of the technology company’s stock worth $38,000 after buying an additional 400 shares during the period. Finally, Bank of America Corp DE lifted its holdings in Kewaunee Scientific by 2,605.9% during the 4th quarter. Bank of America Corp DE now owns 460 shares of the technology company’s stock worth $28,000 after buying an additional 443 shares during the period. Institutional investors own 32.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Kewaunee Scientific in a research note on Thursday, April 2nd. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Kewaunee Scientific presently has a consensus rating of “Hold”.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.